Sriraman A, Dickmanns A, Najafova Z, Johnsen S, Dobbelstein M. CDK4 inhibition diminishes p53 activation by MDM2 antagonists. Cell Death Dis. 2018;9:918 pubmed publisher

Roth S, Hald Ã, Fuchs S, Løkke C, Mikkola I, Flægstad T, et al. MicroRNA-193b-3p represses neuroblastoma cell growth via downregulation of Cyclin D1, MCL-1 and MYCN. Oncotarget. 2018;9:18160-18179 pubmed publisher

Gillen A, Brechbuhl H, Yamamoto T, Kline E, Pillai M, Hesselberth J, et al. Alternative Polyadenylation of PRELID1 Regulates Mitochondrial ROS Signaling and Cancer Outcomes. Mol Cancer Res. 2017;15:1741-1751 pubmed publisher

Dozier C, Mazzolini L, Cénac C, Froment C, Burlet Schiltz O, Besson A, et al. CyclinD-CDK4/6 complexes phosphorylate CDC25A and regulate its stability. Oncogene. 2017;36:3781-3788 pubmed publisher

Jiang J, Huang J, Wang X, Quan Y. MicroRNA-202 induces cell cycle arrest and apoptosis in lung cancer cells through targeting cyclin D1. Eur Rev Med Pharmacol Sci. 2016;20:2278-84 pubmed

Kaukoniemi K, Rauhala H, Scaravilli M, Latonen L, Annala M, Vessella R, et al. Epigenetically altered miR-193b targets cyclin D1 in prostate cancer. Cancer Med. 2015;4:1417-25 pubmed publisher

Jia Y, Domenico J, Swasey C, Wang M, Gelfand E, Lucas J. Modulated expression of genes encoding estrogen metabolizing enzymes by G1-phase cyclin-dependent kinases 6 and 4 in human breast cancer cells. PLoS ONE. 2014;9:e97448 pubmed publisher

Dok R, Kalev P, Van Limbergen E, Asbagh L, Vázquez I, Hauben E, et al. p16INK4a impairs homologous recombination-mediated DNA repair in human papillomavirus-positive head and neck tumors. Cancer Res. 2014;74:1739-51 pubmed publisher

Watanabe H, Pan Z, Schreiber Agus N, DePinho R, Hurwitz J, Xiong Y. Suppression of cell transformation by the cyclin-dependent kinase inhibitor p57KIP2 requires binding to proliferating cell nuclear antigen. Proc Natl Acad Sci U S A. 1998;95:1392-7 pubmed